company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-774365.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-774365.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13711.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,55192.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-55275.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-760737.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-760737.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10913.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10913.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10913.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,267244.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,100000.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,367244.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,367244.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-404406.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1330738.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1330738.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-13711.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-815018.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,61611.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,563620.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,50164.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,613784.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,10913.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10913.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10913.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-168244.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-100000.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-268244.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-268244.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,50164.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,406617.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,18.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78530.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78530.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2204.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,25516.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-55218.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-55218.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,56000.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,56000.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,56000.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,782.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4304.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13391208.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13391208.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25686.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,83858.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8149079.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,418324.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4714261.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-50164.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4764425.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28766.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8870.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37636.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37636.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-300696.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3129160.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1707000.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17250.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4552714.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4552714.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-50164.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-299511.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,678.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-4304.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13289603.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13289603.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14578.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,53292.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10487661.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,282087.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2451985.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2451985.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-32386.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12101.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44487.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44487.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2400779.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,165999.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2566778.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2565220.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68748.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2112.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11850038.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11850038.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14535.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1055984.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7759603.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,223118.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2796798.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2796798.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34018.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-37083.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-400656.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-471757.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-471757.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-100780.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4499221.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,400.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4398841.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4400399.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1131844.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5644.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4253259.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4253259.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14839.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,50099.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1029468.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8636.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3150217.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3150217.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2500.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-39039.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,68954.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,27415.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,27415.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1800000.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,125001.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,25000.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1950001.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1950001.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1172766.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,29331.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5727335.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5727335.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-16468.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,473641.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,40022.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,891814.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4338326.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4338326.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,2499.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-117878.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,331702.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,216323.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,216323.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2249220.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7770884.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-399.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5521265.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5521265.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1399227.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-19834.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6375653.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6375653.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4703.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1369921.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,743696.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,748651.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3508682.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3508682.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22905.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-80949.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-103854.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-103854.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5091847.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45430472.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,40838625.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,40838625.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,37226089.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,191258.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8379139.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8379139.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6697.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-706196.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2001049.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2308603.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4768986.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4768986.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17035.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-181401.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-103737.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-302173.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-302173.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,5191847.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-334607.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4667168.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-309928.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-309928.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5381087.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9183118.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9183118.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7122.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,265973.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1329863.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1125777.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8705937.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8705937.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23692.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-97284.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-120976.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-120976.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,40055.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,40055.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,40055.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:00:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8786858.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10899260.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10899260.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8469.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5624.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1421153.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-608396.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10072410.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10072410.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7270.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-115805.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,10686.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-112389.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-112389.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,334233.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,334233.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,334233.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9850566.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17832251.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17832251.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7122.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5626.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1186414.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5175702.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11457387.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11457387.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,19740.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10686.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9054.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9054.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42771353.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,122258.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,42893611.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,42893611.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31445278.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20894256.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20894256.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6881.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6691.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,853468.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,877480.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19149736.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19149736.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-36853.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-36853.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-36853.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,59117827.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,365608.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,59483435.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,59483435.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40296846.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27227446.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27227446.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7367.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6913.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2146110.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,220056.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24847000.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24847000.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15559.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-41939.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57498.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57498.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,491743.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,491743.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,491743.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24412755.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19472645.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19472645.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7856.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8692.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1778491.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-760204.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18437810.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18437810.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-39200.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-39200.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-39200.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,32256822.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,98478.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32355300.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32355300.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13878290.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17482677.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17482677.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7855.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10145.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2433787.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1578683.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16609573.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16609573.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-149698.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-301112.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-450810.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-450810.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,642750.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,642750.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,642750.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16417633.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20929365.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20929365.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8363.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11234.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4617841.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3112001.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19403928.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19403928.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-74478.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-90529.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-165007.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-165007.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,134863475.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2096450.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,136959925.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,136959925.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,117390990.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21094139.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21094139.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10853.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,13409.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5030391.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,718109.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15321377.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15321377.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-190558.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-302692.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4864.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-498114.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-498114.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,254592.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,254592.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,254592.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15564899.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25015661.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25015661.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26543.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,13917.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5998551.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,177566.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18799084.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18799084.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42678.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-148465.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9172.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-200315.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-200315.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1018.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1018.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1018.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18998381.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22836294.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22836294.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32147.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,15985.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4289147.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2881071.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15617944.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15617944.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-88440.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-303580.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,14036.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-14036.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-392020.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-392020.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10000.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10000.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10000.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15999964.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21156492.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21156492.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,33600.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,16099.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1411592.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-830470.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20525671.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20525671.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27834.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-107487.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-135321.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-135321.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2652310.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2652310.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2652310.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18008682.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19676917.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19676917.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35400.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,17789.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1621659.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-137786.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18139855.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18139855.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8015.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-260115.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-268130.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-268130.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1359049.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1359049.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1359049.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17048936.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14664641.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14664641.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35622.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,18433.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2006087.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4080052.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16684551.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16684551.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-72168.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-72168.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-72168.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,68572635.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,255.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,68572890.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,68572890.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,51816171.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21427330.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21427330.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,36979.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,19195.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1854191.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1288572.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20805537.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20805537.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25968.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-325521.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-351489.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-351489.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21157026.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24401829.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24401829.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38424.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,21197.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1774313.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2918200.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19649695.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19649695.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26908.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-142136.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-11486.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-180530.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-180530.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,44057.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,44057.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,44057.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19786168.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33219048.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33219048.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,40777.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,54981.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2392151.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5781941.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24949198.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24949198.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18812.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-292541.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-311353.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-311353.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3786918.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,75000000.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1084939.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,72298021.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,72298021.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,47037470.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35605302.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35605302.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42222.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,150854.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2453646.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1109368.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34067948.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34067948.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20575.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-314229.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-19999999.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20334803.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20334803.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,89907797.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,107317.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,90015114.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,90015114.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35612363.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1759316.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39390981.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39390981.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,59989.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,155301.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2257879.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8772872.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28144940.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28144940.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-150745.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-356501.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-163925.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-671171.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-671171.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,429895.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,429895.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,429895.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28386216.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,130850.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39506375.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39506375.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66494.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,160590.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2888997.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1773124.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38163418.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38163418.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-262418.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-403496.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-665914.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-665914.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,100107.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,100107.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,100107.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-38729225.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1913956.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55236517.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55236517.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66555.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,245238.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-7032319.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11333002.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-50624041.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-50514305.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-830086.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-359751.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-20420.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1210257.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1210257.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-88312989.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,200000000.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,111687011.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,111687011.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,59962449.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5075614.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31966593.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31966593.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,90701.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,333205.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22946108.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17516281.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26112860.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26222596.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-996909.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-305295.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1302204.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1302204.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8549.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8549.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8549.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27516251.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5457222.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49435514.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49435514.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,191443.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1093554.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3397128.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6043887.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-50797276.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-50797276.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-360872.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-373447.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-20000000.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20734319.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20734319.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,77031258.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,77031258.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,77031258.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5499663.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,5341111.0
